Blood Test Could Improve Active Surveillance for Prostate Cancer
A study found an active surveillance blood test for prostate cancer could predict whether a patient had indolent or aggressive disease.
Read MorePosted by Chris Wolski | Apr 15, 2024 | Prostate |
A study found an active surveillance blood test for prostate cancer could predict whether a patient had indolent or aggressive disease.
Read MorePosted by Andy Lundin | Apr 9, 2024 | Urinalysis & Toxicology |
Nanostics announced an agreement with Alberta Health Services to help drive diagnostic and prognostic innovations in urological care.
Read MorePosted by Andy Lundin | Apr 8, 2024 | Prostate |
A study investigating a single invitation to a PSA blood test to screen for prostate cancer found it had a small impact on reducing deaths.
Read MorePosted by Andy Lundin | Mar 29, 2024 | Prostate |
MRI of the prostate, combined with a blood test, can help find if a prostate lesion is clinically significant cancer, new research suggests.
Read MorePosted by Andy Lundin | Mar 21, 2024 | Cancer |
Ibex’s Galen platform aims to help labs overcome the challenges of increasing demand and diagnostic workloads for cancer diagnostics.
Read More